MedCity News

Nourish Secures $100M for Metabolic Health Clinic

BioMarin’s Mixed Bag of Phase 3 Data Dim Prospects for Rare Disease Drug

A BioMarin Pharmaceutical drug met just one of two main goals of a Phase 3 test in a rare inherited enzyme deficiency with no FDA-approved therapies. The drug, a fusion protein, came from BioMarin’s 2025 acquisition of Inozyme Pharma.

By Frank Vinluan

Health Tech, Startups, Payers, Providers

Conceptual image of a pink piggy bank on a dark blue background encircled by various glowing holographic bar graph and line graph displays, symbolizing the integration of big data and financial technology into personal savings. This horizontal composition illustrates the power of analyzing market trends and using a progress indicator to achieve long-term prosperity and investment success. It explores themes of financial literacy and the digital transformation of banking, where augmented reality tools provide a heads up display for monitoring a return on investment. The visual narrative emphasizes the importance of accuracy and business strategy in modern wealth management, showing how digital marketing and information equipment can empower a business person or consumer to make informed decisions for their home finances and future security.

New Investment Firm Launches to Back Healthcare Startups That Have ‘Earned the Right to Scale’

Fountain Health Partners announced its launch, with plans to back startups approaching or already at profitability, with a clear three- to five-year path to a strategic exit. The investment firm was founded by Joey Campanelli, a former executive at Shields Health Solutions, and Jack Euston, a healthcare investment banker with more than a decade of experience in M&A.

By Katie Adams

MedCity Influencers

Everyone’s Betting on AI to Solve the Physician Shortage —They’re Solving the Wrong Problem

This isn't a supply problem. It's a distribution problem. The physicians exist. The system just isn't getting them where they need to be.

By Dr. Marc Ayoub

Latest Video

Latest News

MedCity Influencers

Stigma Is The Real Delay In Healthcare

The longer someone waits to seek help, the more their condition progresses, the harder it becomes to intervene, and the easier it becomes to keep waiting. Delay compounds. That's what makes it so dangerous, and so worth targeting directly.

By Neil Walker

MedCity Influencers

The Changing Landscape of New Approach Methodologies

Now more than ever, NAMs need to be considered a core aspect of modern drug development – and scientists, decision-makers, regulators and governments must keep pace with this evolving landscape to ensure they are equipped to deliver the next-generation of therapies.

By Paul Brooks

The Power of Real World Data to Study Women’s Health at Scale

Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!

By Veradigm and MedCity News

Consumer / Employer, Policy

How Healthcare Leaders are Reacting to the White House’s Proposed Fertility Benefit Rule

Healthcare leaders are divided over the Trump administration’s proposed rule to expand employer-sponsored fertility benefits, with some praising broader access and others saying it falls short of guaranteeing comprehensive coverage.

By Marissa Plescia

Inviting Investors and Corporate Business Development Leaders to Bullseye

This year, we are hosting a new event called Bullseye: Targeting Healthier Outcomes & Returns on July 23 in Chicago. It's invitation-only and exclusively for healthcare investors and corporate business development leads. Join the waitlist for a chance to be in the room with your peers.

By Arundhati Parmar

Hospitals, Providers

Paper Craft of the Final Piece to Solving a Jigsaw Puzzle on Blue Background Directly Above View.

Sanford Health Continues M&A Push with North Memorial Health Deal

Sanford Health signed a deal to acquire North Memorial Health, which could be its long-sought entry into the Twin Cities market. The move is the latest in a series of expansion efforts for the South Dakota-based health system.

By Katie Adams

BioPharma, Pharma

Bristol Myers, Hengrui Pharma Team Up in Global Drug Research Pact That Could Top $15B

Bristol Myers Squibb is paying $600 million up front to begin a 13-drug collaboration with Hengrui Pharma spanning oncology, hematology, and immunology. That tops a 12-drug pact GSK inked last year with Hengrui, a China-based company that has global growth ambitions.

By Frank Vinluan

MedCity Influencers

Five Ways Technology Can Transform Chronic Care Management

When paired with clinician-led care, it enables a fundamentally different approach to chronic disease management. These tools are designed to augment care teams by reducing administrative burden and allowing clinicians to focus on higher-value care.

By Stephen Stewart

MedCity Influencers

Hand arranging wood block stacking with icon internal organs

AI in Transplant Diagnostics: Turning Complexity into Clinical Clarity

The strongest AI adoption plans follow a simple pattern: start small, validate and scale only when results hold up across sites, shifts and real-world variation. The goal is safer, more personalized care, which is made possible by clinicians receiving earlier signals, better-tailored monitoring and more confident decisions for each patient.

By Tina Liedtky

MedCity Influencers

Digital Fatigue: Healthcare’s Next Patient Experience Crisis

Patients are tuning out digital messages because they receive too many across channels. This is problematic given that digital strategy is critical to reaching consumers and developing trust in today’s economy.

By Katie Logan

Consumer / Employer

About 67% of Employers Cover GLP-1s for Weight Management; That Could Decline in 2027

A new Business Group on Health survey found that while many employers currently cover GLP-1s for weight management, rising costs are prompting some to reconsider that coverage and adopt strategies to control spending.

By Marissa Plescia

Health Tech, Hospitals, Providers

UK, London, low angle view of city financial district modern buildings facades

How Beth Israel Lahey Health Cut Fax Failures From 34% to 4% — and Saved $4 Million

Beth Israel Lahey Health said modernizing its fax infrastructure during a major Epic EHR consolidation helped the health system slash fax failure rates from 34% to 4% and save $4 million. By adopting Retarus’ cloud-based platform, the health system simplified referrals and prescription processing, as well as reduced manual administrative work.

By Katie Adams

Pharma, BioPharma

A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy

Partner Therapeutics’ Bizengri is now FDA approved for treating advanced cases of cholangiocarcinoma driven by NRG1 gene fusions. Partner acquired U.S. rights to this bispecific antibody from Merus in 2024.

By Frank Vinluan

MedCity Influencers

doctor writing on a clipboard while talking on the phone

Critical Care Documentation: Why It’s Different and How It Impacts Patient Care

By embracing better tools and smarter approaches, agencies can reduce the strain on their teams and give their patients the most seamless, high-quality care possible.

By Joe Graw

MedCity Influencers

Listen Closer: What Triage Nurses Hear That Others Miss

For the triage nurse, it comes down to understanding nuance and unique patient needs, whether that’s identifying an acute condition or just lending a listening ear.

By Devin English